Open company graph database — free web & API
Login

Kono Pharmaceutical Co., Ltd.

河野薬品株式会社
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
3
§01

Basic information

BASIC
Head office
4-4-2 Doshomachi, Chuo-ku, Osaka, Osaka Prefecture
Chief executive
Michimune Kono
Capital
94,500,000 JPY
Employees (non-consolidated)
Employees (consolidated)
Start date
1947-05-01
End date
§02

Websites

1 DOMAINS
§03

Business

4
Phenol, cresol, and xylenol businessLogistics Industry Materials BusinessIndustrial chemicals businessCarbon Fiber Business
§04

Related companies

3 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
協力会社(保管)
Supplier
協力会社(蒸留・加工)
Supplier
Chasumi Trading Co., Ltd.
Supplier
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

28 EVENTS

May 1944: Minato Kono, then a director of Maruishi Pharmaceutical Co., Ltd., opened Kono Shoten, a pharmaceutical raw materials trading business.Sources

May 1947: The business was reorganized as a company, engaging in the wholesale of pharmaceutical raw materials and industrial chemicals.Sources

October 1948: Merged with Sowa Pharmaceutical Co., Ltd. and began manufacturing its hemorrhoid treatment product, Hemojinal (discontinued in 1981).Sources

October 1952: Began producing and selling Kurokami, a hair dye for covering gray hair (production discontinued in 1967). With the liberalization of trade, began importing and selling tar-acid cresols and xylenols.Sources

June 1954: Entered into an exclusive agency agreement for the Far East with Productol Chemical Co., then the largest petroleum-based cresol manufacturer in the United States.Sources

October 1955: Entered into an exclusive agency agreement with North Thames Gas Board, a British state-owned cresol manufacturer, and came to account for more than 80% of the national market in imported tar acids.Sources

September 1967: Sumitomo Chemical Co., Ltd., Sumitomo Corporation, and Kono Pharmaceutical Co., Ltd. conducted global marketing research for the development of synthetic cresol.Sources

October 1969: Sumitomo Chemical Co., Ltd. succeeded in developing the world's first synthetic cresol. Kono Pharmaceutical Co., Ltd. became its exclusive agent and established its position as a specialist cresol trading company.Sources

April 1974: Hiroshi Kono was appointed Representative Director and President.Sources

July 1957: Opened a Tokyo office.Sources

June 1981: In response to an increase in the volume of tar acids handled, distribution operations in Osaka and Nagoya were streamlined and consolidated in Osaka.Sources

November 1984: Received recognition as an outstanding corporation from the Osaka Higashi Tax Office.Sources

August 1960: Became the first in Japan to successfully import cresol in bulk. Increased its handling volume and was also appointed as an agent for domestic fractionated-cresol manufacturers, focusing on sales of both domestically produced and imported products.Sources

November 1999: Michihiro Kono was appointed Representative Director and President.Sources

October 2002: New headquarters completed.Sources

October 2002: Began selling pallets as logistics materials.Sources

May 2006: Celebrated the 60th anniversary of its establishment.Sources

December 2006: Received an investment from Osaka Small and Medium Business Investment & Consultation Co., Ltd., bringing its capital to ¥90 million.Sources

October 2007: Established a department for the sale of pallets as logistics materials.Sources

November 2015: Michimune Kono was appointed President and Representative Director.Sources

May 2016: Celebrated the 70th anniversary of the company’s founding.Sources

March 2008: Established the joint venture Jiangsu Lutao Trading Co., Ltd. in China.Sources

January 2012: Capital increased to ¥94.5 million.Sources

October 2021: Received the “Certificate of Health Declaration.”Sources

January 2025: Registered as a business operator under the “Decarbonized Management Declaration.”Sources

March 2025: Declared Security Action (One Star).Sources

July 2025: Obtained ESG Mark certification.Sources

May 2026: Will celebrate the 80th anniversary of the company’s founding.Sources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information3120001077196
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
河野薬品株式会社
Trade name (kana)
コウノヤクヒン
Name in English
Corporation type
301
Address
〒541-0045 大阪府大阪市中央区道修町4丁目4番2号
Postal code
5410045
Prefecture code
27
City code
128
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2019-04-09
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
4095057
METI gBizINFO3120001077196
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
3120001077196
Trade name
河野薬品株式会社
Trade name (kana)
コウノヤクヒン
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
大阪府大阪市中央区道修町4丁目4番2号
Postal code
5410045
Prefecture
大阪府
Prefecture code
27
City or district
大阪市中央区
City code
128
Street address
道修町4丁目4番2号
Organisation type
301
Processing type
01
Correction type
1
Status
Representative
Capital
Employees
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2019-04-09
Key information
3120001077196
§09

Sources & updates

SOURCES
↑